Abstract
Clock genes, major regulators of circadian rhythm, are involved in tumor progression. We have shown that clock genes basic helix-loop-helix (BHLH) transcription factors, differentiated embryonic chondrocyte gene 1 (DEC1/BHLHE40/Sharp2/Stra13) and DEC2 (BHLHE41/Sharp1) play important roles in circadian rhythm, cell proliferation, apoptosis, hypoxia response, various stresses, and epithelial-to-mesenchymal transition (EMT) of tumor cells. Various stresses, such as exposure to transforming growth factor-beta (TGF-β), hypoxia, cytokines, serum-free, and anti-tumor drugs affect DEC1 and DEC2 expression. An increased or decreased expression of DEC1 and DEC2 regulated tumor progression. However, DEC1 and DEC2 have opposite effects in tumor progression, where the reason behind remains unclear. We found that DEC2 has circadian expression in implanted mouse sarcoma cells, suggesting that DEC2 regulates tumor progression under circadian rhythm. In addition to that, we showed that DEC1 and DEC2 regulate target genes via positive or negative feedback system in tumor progression. We propose that DEC1 and DEC2 act as an accelerator or a brake in tumor progression. In this review, we summarize current progress of knowledge in the function of D...Continue Reading
Citations
Apr 21, 2016·Journal of Experimental & Clinical Cancer Research : CR·Baoen JiangHongyan Tian
Nov 2, 2016·PloS One·Daniel Vaiman, Francisco Miralles
Mar 9, 2018·International Journal of Molecular Sciences·Fuyuki SatoYasuteru Muragaki
Apr 29, 2018·Molecular Carcinogenesis·Qin ZhengYang Liu
Dec 6, 2017·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Yanfei JiaXiaoli Ma
Aug 30, 2017·Food & Function·Xiao-Ping WangNa Chang
Feb 6, 2019·Biology of Reproduction·Aleksandar Z BaburskiTatjana S Kostic
Jun 4, 2019·International Journal of Molecular Sciences·Sadia RahmanElitza Markova-Car
Oct 11, 2019·International Journal of Molecular Sciences·Hue Thi LeMasanori Nakata
Feb 20, 2020·Journal of Cellular and Molecular Medicine·Di ZhangEnhua Wang
Aug 7, 2019·Oncotarget·Kazuo AsanomaKiyoko Kato
Feb 28, 2020·Experimental and Therapeutic Medicine·Shuai LiCong-Wei Liu
Jun 25, 2020·Genes & Cancer·Zsofia KissParamita M Ghosh
Aug 25, 2018·Nature Communications·Ho Lam ChanLluis Morey
Mar 17, 2017·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Fengmei Li, Wuyi Liu
Nov 30, 2018·Journal of Cellular Biochemistry·Hongyu LiYunshan Wang
Oct 28, 2019·International Journal of Molecular Sciences·Ssu-Yu ChenShih-Ming Huang
Oct 3, 2019·International Journal of Molecular Sciences·Jin Wook HwangAli G Turhan
Sep 27, 2018·Japanese Journal of Ophthalmology·Naoki KusunoseToshiaki Kubota
Aug 31, 2018·Cell Death & Disease·Cristina GalloAlessia Ciarrocchi
Jul 20, 2017·Histochemistry and Cell Biology·Fuyuki SatoYasuteru Muragaki
Oct 22, 2020·IScience·Yin LiAngela Relógio
Oct 23, 2020·Clocks & Sleep·Fuyuki SatoYasuteru Muragaki
Feb 10, 2021·Clocks & Sleep·Fuyuki SatoYasuteru Muragaki
Mar 2, 2021·EBioMedicine·Laetitia S GasparAna Rita Álvaro
Jan 22, 2019·The American Journal of Pathology·Fuyuki SatoYasuteru Muragaki
Apr 14, 2021·Oncogene·Francesca BattaglinHeinz-Josef Lenz
Aug 4, 2020·Mechanisms of Ageing and Development·Kateřina BalounováJiří Pácha
May 16, 2021·Journal of Experimental & Clinical Cancer Research : CR·Xiao YangYa-Ling Tang
May 9, 2021·Journal of Biochemistry·Momoko HayashiKazuya Yamada
Feb 21, 2021·Carcinogenesis·Suliman KhanMengzhou Xue
Jul 4, 2021·International Immunopharmacology·Ning-Lang YuanDi Zhang
Jun 12, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yuqiang LiangBaolan Lu